Sign in |Join free
Keywords: 18162-48-6 , 872-50-4 , Methylene Chloride , naphthalene , THF , Titanium Dioxide

Chemical Products List

Drug Metabolism in Human Brain

ChemicalBookProduct Catalog API Nervous system drugs Drug Metabolism in Human Brain

During the recovery process of cerebrovascular diseases, except from the necessary physical therapy and functional exercise, cerebral metabolic pharmacological activation drugs should be applied. The application of these drugs could improve the oxygen and glucose utilization of brain cells and improve brain and reduce neurological disorders caused by ischemia and anoxia. Cerebral metabolic regulation drugs also play a certain rule in promoting the recovery of brain function.

Click on the specific product, view the latest prices of the products, information, serving information
Structure Chemical Name CAS MF
Ferulic Acid Ferulic Acid 1135-24-6 C10H10O4
Coluracetam Coluracetam 135463-81-9 C19H23N3O3
Rivastigmine Rivastigmine 123441-03-2 C14H22N2O2
Pramiracetam Pramiracetam 68497-62-1 C14H27N3O2
Aniracetam Aniracetam 72432-10-1 C12H13NO3
Piracetam Piracetam 7491-74-9 C6H10N2O2
Oxiracetam Oxiracetam 62613-82-5 C6H10N2O3
Entacapone Entacapone 130929-57-6 C14H15N3O5
Umibecestat Umibecestat 1387560-01-1 C19H15ClF7N5O2
Irdabisant hydrochloride Irdabisant hydrochloride 1005398-61-7 C18H24ClN3O2
NEOTROFIN NEOTROFIN 192564-13-9 C15H12N5O4.K
Tirilazadmesylate Tirilazadmesylate 110101-66-1 C38H52N6O2
L-Valine, L-tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginyl-L-lysyl-L-leucyl-L-seryl-L-seryl-L-isoleucyl-L-α-glutamyl-L-seryl-L-α-aspartyl-, acetate (1:) L-Valine, L-tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginyl-L-lysyl-L-leucyl-L-seryl-L-seryl-L-isoleucyl-L-α-glutamyl-L-seryl-L-α-aspartyl-, acetate (1:) 2273883-75-1
1,4,8-Triazaspiro[4.5]decan-2-one, 8-methyl-1-(phenylmethyl)-, hydrochloride, hydrate (1:2:1) 1,4,8-Triazaspiro[4.5]decan-2-one, 8-methyl-1-(phenylmethyl)-, hydrochloride, hydrate (1:2:1) 2375909-85-4 C15H21N3O.2ClH.H2O
ispronicline ispronicline 252870-53-4 C14H22N2O
Crenezumab Crenezumab 1095207-05-8
Opicinumab Opicinumab 1422268-07-2
2-(dimethylamino)ethyl [5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyl succinate, salt with maleic acid (1:2) 2-(dimethylamino)ethyl [5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyl succinate, salt with maleic acid (1:2) 53659-00-0 C24H32N2O14
(R)-2-Propyloctanoic acid (R)-2-Propyloctanoic acid 185517-21-9 C11H22O2
Elenbecestat(E2609) Elenbecestat(E2609) 1388651-30-6 C19H18F3N5O2S
Dezamizumab Dezamizumab 1662664-56-3
Gosuranemab Gosuranemab 1788032-39-2
5-bromo-3-(10-methoxy-1,6-dimethylergolin-8beta-ylmethoxycarbonyl)pyridinium hydrogen [R-(R*,R*)]-tartrate 5-bromo-3-(10-methoxy-1,6-dimethylergolin-8beta-ylmethoxycarbonyl)pyridinium hydrogen [R-(R*,R*)]-tartrate 32222-75-6 C28H32BrN3O9
Bepranemab Bepranemab 2244960-75-4
Anselamimab Anselamimab 2414866-63-8
(3S)-3-(5-chloro-2-methoxy-phenyl)-3-fluoro-6-(trifluoromethyl)-1H-ind ol-2-one (3S)-3-(5-chloro-2-methoxy-phenyl)-3-fluoro-6-(trifluoromethyl)-1H-ind ol-2-one 187523-35-9 C16H10ClF4NO2
Eplontersensodium Eplontersensodium 2131025-75-5
Iluzanebart Iluzanebart 2733621-19-5
bapineuzumab bapineuzumab 648895-38-9
Nivegacetor Nivegacetor 2443487-67-8 C23H25F2N7O2
Pyridine, 2-Methyl-3-[(2S)-2-pyrrolidinylMethoxy]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) Pyridine, 2-Methyl-3-[(2S)-2-pyrrolidinylMethoxy]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) 945405-37-8 C15H22N2O7
UE2343 UE2343 1346013-80-6 C19H19N5O2S
4H-Pyrazolo[4,3-c]quinolin-4-one, 1,5-dihydro-7-(2-methoxy-3,5-dimethyl-4-pyridinyl)-1-[(3S)-tetrahydro-3-furanyl]- 4H-Pyrazolo[4,3-c]quinolin-4-one, 1,5-dihydro-7-(2-methoxy-3,5-dimethyl-4-pyridinyl)-1-[(3S)-tetrahydro-3-furanyl]- 1429509-82-9 C22H22N4O3
Imidazo[1,2-a]pyrazine, 8-[(2-fluorophenyl)methyl]-6-[5-(trifluoromethyl)-1H-1,2,4-triazol-3-yl]- Imidazo[1,2-a]pyrazine, 8-[(2-fluorophenyl)methyl]-6-[5-(trifluoromethyl)-1H-1,2,4-triazol-3-yl]- 2201048-82-8 C16H10F4N6
Posdinemab Posdinemab 2517973-04-3
Amlenetug Amlenetug 2850367-41-6
Tat-NR2B9c Tat-NR2B9c 500992-11-0 C105H188N42O30
ZONAMPANEL ZONAMPANEL 210245-80-0 C13H9N5O6
Icopezil maleate Icopezil maleate 145815-98-1 C27H29N3O6
Ozanezumab Ozanezumab 1310680-64-8
Tilavonemab Tilavonemab 2096513-89-0
Elezanumab Elezanumab 1791416-49-3
Imidazo[1,5-a]pyrazin-8(7H)-one, 6-[(3S,4S)-4-methyl-1-(2-pyrimidinylmethyl)-3-pyrrolidinyl]-3-(tetrahydro-2H-pyran-4-yl)- Imidazo[1,5-a]pyrazin-8(7H)-one, 6-[(3S,4S)-4-methyl-1-(2-pyrimidinylmethyl)-3-pyrrolidinyl]-3-(tetrahydro-2H-pyran-4-yl)- 2062661-53-2 C21H26N6O2
LEUCOFORM LEUCOFORM 613-11-6 C16H19N3S
Latozinemab Latozinemab 2376132-27-1
Unasnemab Unasnemab 2379805-59-9
Quilostigmine Quilostigmine 139314-01-5 C23H27N3O2
Piracetam Piracetam
4-(aminomethyl)-1-benzyl-pyrrolidin-2-one 4-(aminomethyl)-1-benzyl-pyrrolidin-2-one 97205-35-1 C12H16N2O
tirilazad tirilazad 110101-67-2 C39H56N6O5S
abrineurin abrineurin 178535-92-7
Suronacrine maleate Suronacrine maleate 113108-86-4 C24H24N2O5
3,6-Diazabicyclo[3.2.0]heptane, 3-(5,6-dichloro-3-pyridinyl)-, (1S,5S)-, Monobenzenesulfonate 3,6-Diazabicyclo[3.2.0]heptane, 3-(5,6-dichloro-3-pyridinyl)-, (1S,5S)-, Monobenzenesulfonate 876170-44-4 C16H17Cl2N3O3S
Piperidine, 1-[3-[3-(4-chlorophenyl)propoxy]propyl]- Piperidine, 1-[3-[3-(4-chlorophenyl)propoxy]propyl]- 362665-56-3 C17H26ClNO
Xaliproden Xaliproden 135354-02-8 C24H22F3N
Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, phenylcarbamate (ester), (3aR,8aS)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt) (9CI) Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, phenylcarbamate (ester), (3aR,8aS)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt) (9CI) 865795-23-9 C24H29N3O8
Vanutide cridificar Vanutide cridificar 886584-10-7
Pegorgotein Pegorgotein 155773-57-2 C7H13NO4
Research Grade Usilnetug Research Grade Usilnetug 2770861-19-1
N-[(3S)-1-[4-[(3-fluorophenyl)methoxy]phenyl]-5-oxopyrrolidin-3-yl]acetamide N-[(3S)-1-[4-[(3-fluorophenyl)methoxy]phenyl]-5-oxopyrrolidin-3-yl]acetamide 676479-06-4 C19H19FN2O3
4-(acetamido)benzoic acid, compound with 2-(dimethylamino)ethanol (1:1) 4-(acetamido)benzoic acid, compound with 2-(dimethylamino)ethanol (1:1) 3635-74-3 C9H9NO3.C4H11NO
deanol aceglumate deanol aceglumate 3342-61-8 C11H22N2O6
1,3-Benzenedisulfonic acid, 4-[[(1,1-dimethylethyl)oxidoimino]methyl]-,disodium salt 1,3-Benzenedisulfonic acid, 4-[[(1,1-dimethylethyl)oxidoimino]methyl]-,disodium salt 168021-79-2 C11H14NNa2O7S2
2,4(1H,3H)-Pyrimidinedione, 6-[4-[[3-(difluoromethoxy)-2-pyridinyl]oxy]-2-methylphenyl]-1,5-dimethyl-, (-)- 2,4(1H,3H)-Pyrimidinedione, 6-[4-[[3-(difluoromethoxy)-2-pyridinyl]oxy]-2-methylphenyl]-1,5-dimethyl-, (-)- 1643489-35-3 C19H17F2N3O4
Research Grade Trontinemab (DHC12508) Research Grade Trontinemab (DHC12508) 2568868-35-7
Nevadistinel Nevadistinel 2181816-92-0 C15H18N2O3
besipirdine besipirdine 130953-69-4 C16H17N3.ClH
Quinoline, 2-[[4-[1-methyl-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]methyl]- Quinoline, 2-[[4-[1-methyl-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]methyl]- 898562-94-2 C25H20N4O
PAZ 417 PAZ 417 481629-87-2 C28H27NO3
Pramiracetam hydrochloride Pramiracetam hydrochloride 75733-50-5 C14H27N3O2.ClH
Monohydrochloride Monohydrochloride 119600-43-0 ClH
ABT 894 ABT 894 799279-80-4 C10H11Cl2N3
Bradanicline hydrochloride Bradanicline hydrochloride 1111941-90-2 C22H24ClN3O2
Ponezumab Ponezumab 1178862-65-1
Dihydroergotoxine mesylate Dihydroergotoxine mesylate 8067-24-1 C20H29N3O5S
SAM-531 SAM-531 925448-93-7 C22H23N3O3S
JNJ31001074AAC JNJ31001074AAC 1103522-80-0 C19H30ClN3O3
1,3-Dihydro-1-phenyl-3,3-bis(4-pyridinylmethyl)-2H-indol-2-one dihydrochloride 1,3-Dihydro-1-phenyl-3,3-bis(4-pyridinylmethyl)-2H-indol-2-one dihydrochloride 105431-72-9 C26H21N3O
CPHPC CPHPC 224624-80-0 C16H24N2O6
Tazomeline citrate Tazomeline citrate 175615-45-9
Atabecestat Atabecestat 1200493-78-2 C18H14FN5OS
Cerlapirdine hydrochloride Cerlapirdine hydrochloride 925447-04-7 C22H23N3O3S. HCl
(4R)-1-[(5-Chloro-1H-1,2,4-triazol-1-yl)methyl]-4-(3,4,5-trifluorophenyl)-2-pyrrolidinone (4R)-1-[(5-Chloro-1H-1,2,4-triazol-1-yl)methyl]-4-(3,4,5-trifluorophenyl)-2-pyrrolidinone 1651179-19-9 C13H10ClF3N4O
talsaclidine fumarate talsaclidine fumarate 147025-54-5 C10H15NO.C4H4O4
Apaxifylline Apaxifylline 151581-23-6 C16H22N4O3
2-Methyl-3-((2S)-pyrrolidin-2-ylmethoxy)pyridine 2-Methyl-3-((2S)-pyrrolidin-2-ylmethoxy)pyridine 161417-03-4 C11H16N2O
1-Methyl-1,2,5,6-tetrahydropyridine-3-carbaldehyde (E)-O-methyloxime hydrochloride 1-Methyl-1,2,5,6-tetrahydropyridine-3-carbaldehyde (E)-O-methyloxime hydrochloride 139886-04-7 C8H15ClN2O
9-Amino-1,2,3,4-tetrahydro-acridin-1-ol, maleate 9-Amino-1,2,3,4-tetrahydro-acridin-1-ol, maleate 118909-22-1 C17H18N2O5
but-2-enedioic acid but-2-enedioic acid 142852-51-5 C25H32N2O.C4H4O4
Begacestat Begacestat 769169-27-9 C9H8ClF6NO3S2
Solanezumab Solanezumab 955085-14-0
AVex-73 AVex-73 195615-83-9 C19H23NO
Irdabisant Irdabisant 1005402-19-6 C18H23N3O2
Alvameline maleate Alvameline maleate 219581-36-9 C13H19N5O4
Troriluzole Troriluzole 1926203-09-9 C15H16F3N5O4S
1,4,8-Triazaspiro[4.5]decan-2-one, 8-methyl-1-(phenylmethyl)- 1,4,8-Triazaspiro[4.5]decan-2-one, 8-methyl-1-(phenylmethyl)- 1224591-33-6 C15H21N3O
E2027 maleate E2027 maleate 1630083-70-3 C26H26N4O7
Licostinel Licostinel 153504-81-5 C8H3Cl2N3O4
2-(4-Chloro-3-fluorophenoxy)-N-[(3S,6R)-6-[5-[2-(trifluoromethoxy)ethoxy]-1,3,4-oxadiazol-2-yl]-3-piperidinyl]acetamide 2-(4-Chloro-3-fluorophenoxy)-N-[(3S,6R)-6-[5-[2-(trifluoromethoxy)ethoxy]-1,3,4-oxadiazol-2-yl]-3-piperidinyl]acetamide 2518151-57-8 C18H19ClF4N4O5
5,5-Bis(4-pyridylmethyl)-5H-cyclopenta[2,1-b:3,4-b'']dipyridine hydrate 5,5-Bis(4-pyridylmethyl)-5H-cyclopenta[2,1-b:3,4-b'']dipyridine hydrate 139781-09-2 C23H20N4O
HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase
Copyright © 2016 ChemicalBook All rights reserved.